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Abstract – Apoptosis was studied in the lungs of pigs during an infection with a European strain of
porcine reproductive and respiratory syndrome virus (PRRSV) and it was examined if cytokines
were involved in the induction of apoptosis. Twenty-two 4- to 5-week-old gnotobiotic pigs were
inoculated intranasally with 106.0 TCID50 of the Lelystad virus and euthanised between 1 and
52 days post inoculation (PI). The lungs and broncho-alveolar lavage (BAL) cells were assessed
both for virus replication and apoptosis; BAL fluids were examined for interleukin (IL)-1, tumour
necrosis factor-alpha and IL-10. Double-labellings were conducted to determine the relation
between virus replication and apoptosis and to identify the apoptotic cells. Apoptosis occurred in
both infected and non-infected cells. The percentages of infected cells, which were apoptotic,
ranged between 9 and 39% in the lungs and between 13 and 30% in the BAL cells. The majority of
apoptotic cells were non-infected. Non-infected apoptotic cells in the lungs were predominantly
monocytes/macrophages, whereas those in the broncho-alveolar spaces were predominantly
lymphocytes. The peak of apoptosis in the lungs at 14 days PI was preceded by a peak of IL-1 and
IL-10 production at 9 days PI, suggesting a possible role of these cytokines in the induction of
apoptosis in non-infected interstitial monocytes/macrophages. However, the latter hypothesis was
not confirmed in vitro, since blood monocytes or alveolar macrophages did not undergo apoptosis
after treatment with recombinant porcine IL-1or IL-10. 
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1. INTRODUCTION
Apoptosis is a physiological mechanism
of cell death important for normal cellular
turnover that is characterised by internu-
cleosomal DNA degradation and pro-
nounced morphological changes [35]. It
also occurs during viral infections and
* Correspondence and reprints
Tel.: (32) 9 264 73 65; fax: (32) 9 264 74 95; e-mail: maurice.pensaert@rug.ac.be
250 G. Labarque et al.
there is mounting evidence that it can con-
tribute directly to viral pathogenesis [8].
Recently, it has been demonstrated that
the porcine reproductive and respiratory
syndrome virus (PRRSV) induces apopto-
sis in the lungs [7, 17, 24, 27]. On a mor-
phological basis, the apoptotic cells are
assumed to be alveolar and pulmonary
intravascular macrophages and mononu-
clear cells in the alveolar septa. Double-
labelling experiments indicate that most
apoptotic cells are non-infected [24, 27].
An infection of the lungs with PRRSV
has some peculiar cellular features that
may be attributed to apoptosis. Firstly, it is
characterised by changes in the population
of broncho-alveolar monocytes/macro-
phages, consisting of a reduction of the
population of well-differentiated macro-
phages and an influx of new monocytes
[16]. Since apoptosis is an important
mechanism of the cell population control
in normal tissue homeostasis, it may be
involved in the regulation of the number of
monocytes/macrophages during this mas-
sive influx of new monocytes. Secondly,
PRRSV causes only minimal lung inflam-
mation [21] and neutrophil infiltration [16,
31], which also may be attributed to the
involvement of apoptotic processes, since
apoptotic bodies are phagocytised by resi-
dent macrophages without provoking an
inflammatory response.
Viral glycoprotein GP5 has been shown
to be involved in apoptosis of the PRRSV-
infected cell [26]. However, the mecha-
nism of apoptosis in the non-infected cell
is unknown. It has been demonstrated that
cytokines, such as tumour necrosis factor-
alpha (TNF-) [18], interferon-alpha
(IFN-) [28], interleukin (IL)-1 [6, 11] and
interleukin-10 [12, 33] can induce apopto-
sis. A PRRSV infection generally fails to
induce substantial amounts of IFN- [1,
30, 32]. This argues against a possible role
of this cytokine in PRRSV-induced apop-
tosis. IL-1, however, is produced at high
levels in the lungs of PRRSV-infected pigs
from 3 till 10 days after inoculation [31]
and a weak TNF- production has been
demonstrated at 12 and 13 days after inoc-
ulation [32]. Furthermore, the induction of
IL-10 mRNA in alveolar macrophages has
been reported in PRRSV-infected pigs
[29].
In the present study, the kinetics of
apoptosis both in the lungs and broncho-
alveolar lavage (BAL) cells was investi-
gated in gnotobiotic pigs upon infection
with a European strain of PRRSV, with the
purpose of having a better understanding
on its potential role in the pathogenesis.
Furthermore, it was examined if IL-1,
TNF- and IL-10 may be involved in the
induction of apoptosis during a PRRSV
infection. 
2. MATERIALS AND METHODS
2.1. Virus strain
A fifth passage on pulmonary alveolar
macrophages (PAMs) of the Lelystad
strain of PRRSV [34] was used.
2.2. Pigs and experimental design
A total of twenty-nine caesarean-
derived colostrum-deprived (CDCD) pigs
were used. They were housed in isolation
facilities. Twenty-two pigs were inocu-
lated intranasally at the age of 4 to 5 weeks
with 106.0 TCID50 of the Lelystad virus in
3 mL phosphate-buffered saline (PBS)
(1.5 mL in each nostril). The remaining
seven pigs were left non-inoculated and
served as negative controls. One to three of
the PRRSV-inoculated pigs were eutha-
nised at 1 (n = 1), 3 (n = 2), 5 (n = 2), 7 (n =
3), 9 (n = 3), 14 (n = 3), 20 (n = 1), 25 (n =
2), 30 (n = 1), 35 (n = 2), 40 (n = 1) and 52
(n = 1) days post inoculation (PI) by intra-
peritoneal injection with an overdose of
barbiturates (Natriumpentobarbital® 20%,
IC KELA, Hoogstraten, Belgium). The
control pigs were euthanised at 4 (n = 2),
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5 (n = 1), 6 (n = 1), 8 (n = 2) and 10 (n = 1)
weeks of age. 
The right lung was used for broncho-
alveolar lavage and samples from the left
apical, cardiac and diaphragmatic lung
lobes were collected for quantification
of the infected cells and detection of
apoptosis.
2.3. Collection of samples
The right lung was lavaged using a pre-
viously described method [16]. The BAL
fluid was centrifuged (400  g, 10 min,
4 °C) to separate cells and cell-free lavage
fluid. 
Cell pellets were resuspended in PBS.
The total number of BAL cells and their
differentiation were determined and the
results were published earlier 16. Cyto-
centrifuge preparations of BAL cells were
made by centrifuging at 140g for 5 min.
Preparations were fixed in acetone for
20 min at –20 °C for quantification of the
infected cells, or in 4% paraformaldehyde
for 10 min at room temperature for detec-
tion of apoptosis. 
Cell-free BAL fluids were concentrated
10 times by dialysis against a 20% w/v
solution of polyethylene glycol (mol.
mass 20 000), cleared of residual virus by
ultra-centrifugation at 100 000  g [31],
aliquoted and stored at –70 °C, until anal-
ysis in cytokine bioassays (IL-1, TNF-)
or cytokine ELISA (IL-10).
Tissue samples from the left lung lobes
were embedded in methylcellulose medium
and frozen at –70 °C. Cryostat sections (5
to 8 m) were made and fixed in acetone for
20 min at –20 °C for quantification of
infected cells, or in 4% paraformaldehyde
for 10 min at room temperature for detec-
tion of apoptosis.
2.4. Virological examinations
PRRSV-infected cells in the lung tissue
and BAL cells were quantified using
a streptavidin-biotin immunofluorescence
technique [16]. In the lung tissue, a distinc-
tion was made between single infected
cells and viral antigen-positive foci. Viral
antigen-positive foci were defined as areas
in the lung tissue containing groups of
three or more PRRSV-infected cells and
cellular debris 16.
2.5. Detection of apoptosis
Cytocentrifuge preparations of BAL
cells and cryostat sections of lung tissue
were processed for enzyme terminal deoxy-
nucleotidyl transferase (TdT)-mediated
dUTP nick end labelling (TUNEL) using
an In Situ Cell Death Detection Kit, Fluo-
rescein (Roche Diagnostics Belgium,
Brussel, Belgium) according to the manu-
facturer’s instructions. Briefly, cytocentri-
fuge preparations and cryostat sections,
fixed in 4% paraformaldehyde, were
treated with Triton X-100 (0.1%) at 4 °C
for 2 min. Then, the preparations were sub-
jected to an enzymatic incorporation of
digoxygenin-labelled nucleotide with TdT.
Finally, the preparations were washed
with PBS, mounted in a glycerin-PBS
solution (0.9:0.1, v/v) with 2.5% 1,4-
diazobicyclo(2.2.2)octane (DABCO) (Jans-
sen Chimica, Beerse, Belgium) and apop-
totic cells were detected and enumerated
by fluorescence microscopy (Leica DM
RBE, Wild Leitz GmbH, Heidelberg, Ger-
many). One cytocentrifuge preparation and
three cryostat sections (one of each lung
lobe; standard deviation  500 cells per
100 mm2 lung tissue) were examined per
pig. At least 1 000 cells per cytocentrifuge
preparation and 20 mm2 lung tissue per
cryostat section were analysed.
2.6. Double-labelling experiments
Double-labelling experiments were
conducted to determine the relation
between PRRSV replication and apoptosis.
Briefly, cytocentrifuge preparations and
cryostat sections, fixed in 4% paraformal-
dehyde, were treated with Triton X-100
(0.1%) at 4 °C for 2 min. The preparations
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were first incubated with a pool of mono-
clonal antibodies (MAb) against the
PRRSV nucleocapsid protein (dilution
1/100 of WBE1 and WBE4-6) [9]. Subse-
quently, the preparations were subjected to
an enzymatic incorporation of digoxy-
genin-labelled nucleotide with TdT and
then incubated with goat anti-mouse
TexasRed (dilution 1/100) (Amersham
Biosciences, Buckinghamshire, United
Kingdom).
Double-labelling experiments were
conducted to determine the percentages of
apoptotic cells in the subpopulations of
41D3+ cells (monocytes/macrophages),
CD2+ cells (T lymphocytes and natural
killer (NK) cells), CD4+ cells (T helper
cells), CD8+ cells (cytotoxic T cells and
NK cells) and wCD1+ cells (B lym-
phocytes). The percentages in the subpopu-
lation of monocytes/macrophages were
determined using MAb 41D3, directed
against the putative PRRSV receptor, a
210-kDa protein expressed in macro-
phages [10]. Briefly, cytocentrifuge prepa-
rations of BAL cells and cryostat sections
of lung tissue, fixed in 4% paraformalde-
hyde, were treated with Triton X-100
(0.1%) at 4 °C for 2 min. The preparations
were first incubated with MAb 41D3 (dilu-
tion 1/100). Subsequently, the preparations
were subjected to an enzymatic incorpora-
tion of digoxygenin-labelled nucleotide
with TdT and then incubated with goat
anti-mouse TexasRed (dilution 1/100)
(Amersham Biosciences, Buckingham-
shire, United Kingdom). The percentages
of apoptotic cells in the subpopulations of
CD2+, CD4+ and CD8+ cells were deter-
mined using MAbs MSA4 [19], 74-12-4
[20] and 76-2-11 [36], respectively.
The percentages in the subpopulation of
B lymphocytes were determined using
MAb 76-7-4, directed against wCD1 [4].
Briefly, cytocentrifuge preparations of
BAL cells were first incubated with the
respective MAbs and subsequently with
goat anti-mouse TexasRed (dilution 1/100)
(Amersham Biosciences, Buckingham-
shire, United Kingdom). Then, the prepa-
rations were treated with Triton X-100
(0.1%) at 4 °C for 2 min. Subsequently,
the preparations were subjected to an
enzymatic incorporation of digoxygenin-
labelled nucleotide with TdT.
2.7. Cytokine bioassays and ELISA
IL-1 was determined in a proliferation
assay using D10(N4)M cells [14, 15]. One
unit of IL-1 activity was defined as the
reciprocal of the dilution producing 50%
proliferation of D10(N4)M cells. To assign
bioactivity to IL-1, monoclonal rat anti-
mouse IL-1 receptor type 1 antibodies
(R&D Systems, Abingdon, United King-
dom) were included in the assay.
TNF- was determined in a cytotoxicity
assay in PK(15) subclone 15 cells [3]. One
unit of TNF- activity was defined as
the reciprocal of the dilution producing
50% cytotoxicity. Cytotoxic activity was
confirmed to be induced by TNF- by neu-
tralisation of the samples with rabbit anti-
human TNF- (Innogenetics, Zwijnaarde,
Belgium).
IL-10 was determined in a commercial
ELISA for porcine IL-10 (Biosource
Europe, Nivelles, Belgium) according to
the manufacturer’s instructions.
2.8. In vitro experiments
Porcine peripheral blood mononuclear
cells (PBMCs) were isolated from
heparinised venous blood by Ficoll-
PaqueTM Plus (Amersham Biosciences,
Buckinghamshire, United Kingdom) den-
sity sedimentation. PBMCs were seeded in
24-well cell culture plates (Nunc A/S,
Roskilde, Denmark) at a concentration of
107 cells per well. Monocytes were iso-
lated from PBMCs by adherence on a cul-
ture flask for 2 h at 37 °C, 5% CO2.  Non-
adherent cells were removed by washing
and the adherent cells were cultured at
37 °C overnight. After an additional wash-
ing, the final adherent population was used
as the source of blood monocytes. Porcine
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alveolar macrophages were obtained by
means of a broncho-alveolar lavage and
seeded in 24-well cell culture plates (Nunc
A/S, Roskilde, Denmark) at a concentra-
tion of 106 cells per well. One day after
seeding, blood monocytes and alveolar
macrophages were treated with recom-
binant porcine IL-1(gift from A. Billiau,
Leuven, Belgium) at a concentration of
200 U/mL (75  103 ng/mL) or with
recombinant porcine IL-10 (Biosource
Europe, Nivelles, Belgium) at concentra-
tions of 1, 10, or 100 ng/mL. Functional
activity of both recombinant porcine IL-1
and recombinant porcine IL-10 had been
proven in a proliferation assay using
D10(N4)M cells 14, 15 and the mouse
mast cell line D36 23, respectively.
Untreated cells were included as controls.
Morphological analysis of the cells was
performed daily with a contrast-phase
Olympus microscope (Hamburg, Ger-
many). The cells were harvested at 96 h
after treatment. Cytocentrifuge prepara-
tions were made, fixed in 4% paraformal-
dehyde for 10 min at room temperature
and processed for enzyme terminal deoxy-
nucleotidyl transferase (TdT)-mediated
dUTP nick end labelling (TUNEL) using
an In Situ Cell Death Detection Kit, Fluo-
rescein (Roche Diagnostics Belgium,
Brussel, Belgium) according to the manu-
facturer’s instructions. Apoptotic cells
were detected and enumerated by fluores-
cence microscopy (Leica DM RBE, Wild
Leitz GmbH, Heidelberg, Germany)
3. RESULTS
3.1. Quantification of PRRSV-infected 
and apoptotic cells in lung tissue 
(Fig. 1)
PRRSV-infected cells were observed
from 3 until 25 days PI with a maximal
number of 61 cells/100 mm2 at 7 days PI.
Viral antigen-positive foci were observed
between 3 and 14 days PI with a maximal
number of 37 foci/100 mm2 at 9 days PI
(not shown).
Apoptotic cells were detected in the
lung tissue of both non- and PRRSV-inocu-
lated pigs. In the seven non-inoculated
control pigs, the mean number was 1350 
263 cells/100 mm2. In PRRSV-inoculated
pigs, mean numbers were similar to those
of non-inoculated pigs until 3 days PI. The
mean numbers increased significantly
from 1800  424 cells/100 mm2 at 3 days
PI to a level of 4800–4967  1054–
1097 cells/100 mm2 at 7–9 days PI (P <
0.05; one-way ANOVA) and then peaked
at 8330  1070 cells/100 mm2 at 14 days
PI. From 20 days PI, the mean numbers
returned to those of non-inoculated pigs.
Double-labellings revealed that within
the population of infected cells, apoptosis
was detected from 5 until 25 days PI with
percentages ranging between 9 and 39%.
The majority of apoptotic cells (> 99%)
were non-infected. There was a spatial
correlation between the sites of PRRSV
replication and apoptosis. Non-infected
apoptotic cells were more abundant in viral
antigen-positive foci and they were fre-
quently seen in close proximity to infected
cells (not shown).
Double-labelling experiments with MAb
41D3 revealed that 76 to 88% of the apop-
totic cells were of the monocyte/macro-
phage lineage.
3.2. Quantification of PRRSV-infected 
and apoptotic cells in the broncho-
alveolar spaces (Fig. 2)
PRRSV-infected cells were first
observed at 1 day PI (3  106 cells),
increased to a maximum of 15 106 cells
at 9 days PI, decreased to 3 106 cells at
14 days PI and remained at levels of 0.5-
1 106 cells until 40 days PI.
Apoptotic cells were detected in the
broncho-alveolar spaces of both non- and
PRRSV-inoculated pigs. In the seven non-
inoculated control pigs, the mean number
was 5.3  1.8  106. In PRRSV-inoculated
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pigs, the mean numbers were similar to
those of non-inoculated pigs until 3 days
PI. The mean numbers increased signifi-
cantly from 6.6  1.7106 at 3 days PI to
a first maximum of 41.4  10.8 106 at
9 days PI (P < 0.05; one-way ANOVA),
then remained at the same level until
20 days PI and reached a second maximum
of 63.0  31.0106 at 25 days PI. From
35 days PI onwards, the mean numbers
Figure 1. Quantification of infected and apoptotic cells in lung tissue (/100 mm2) throughout a
PRRSV infection.
Values at day 0 represent the numbers of infected and apoptotic cells of two non-inoculated control
pigs euthanised at 4 weeks of age.
Figure 2. Quantification of infected and apoptotic broncho-alveolar lavage (BAL) cells ( 106)
throughout a PRRSV infection.
Values at day 0 represent the numbers of infected and apoptotic cells of two non-inoculated control
pigs euthanised at 4 weeks of age.
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Figure 3. Interleukin-1 (IL-1), tumour necrosis factor-alpha (TNF-) and interleukin-10 (IL-10)
levels in broncho-alveolar lavage (BAL) fluids throughout a PRRSV infection. The dots represent
individual cytokine levels; the lines represent means at each time point.
Values at day 0 represent the cytokine levels of two non-inoculated control pigs euthanised at
4 weeks of age.
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of apoptotic cells of PRRSV-inoculated
pigs were not different from those of non-
inoculated pigs.
Double-labellings revealed that within
the population of infected BAL cells,
apoptosis was detected until 25 days PI
with percentages ranging between 13 and
30% and that the majority of apoptotic
cells (> 99%) were non-infected.
Mean percentages of apoptotic cells
remained constant in the total population
of BAL cells and in the subpopulation of
monocytes/macrophages (41D3+ cells). In
the subpopulation of T lymphocytes and
NK cells, mean percentages reached a
maximum at 7 (CD8+ cells) or 9 days PI
(CD2+ and CD4+ cells), sharply decreased
thereafter and then remained at constant
levels until 52 days PI. In the subpopula-
tion of B lymphocytes (wCD1+ cells),
apoptotic cells peaked at 5 to 9 days PI and
decreased sharply thereafter.
3.3. IL-1, TNF- and IL-10 production 
in BAL fluids (Fig. 3)
A low level of IL-1 (71 U/mL) was found
in one out of the seven non-inoculated pigs.
The other control pigs had no detectable
amounts of IL-1. All PRRSV-inoculated
pigs had detectable IL-1 production. The
pig euthanised at 1 day PI had an IL-1 titre
of 483 U/mL. Mean IL-1 titres increased
from 240 U/mL at 3 days PI to a maximum
of 1265 U/mL at 9 days PI, decreased to
263 U/mL at 14 days PI and remained at
levels of 121–267 U/mL until 52 days PI.
All non-inoculated control pigs were
negative for TNF-. After PRRSV inocu-
lation, TNF- was only found in the three
pigs euthanised at 14 days PI, at low levels
(32–109 U/mL).
All non-inoculated control pigs were
negative for IL-10. After PRRSV inocula-
tion, IL-10 was found starting from 5 days
PI (19 pg/mL). Mean IL-10 levels reached
a maximum of 139 pg/mL at 9 days PI,
decreased to 14 pg/mL at 14 days PI and
remained at levels of 8–17 pg/mL until
25 days PI.
3.4. Quantification of apoptotic cells 
after in vitro treatment with 
recombinant porcine IL-1
or IL-10
No morphological features of apoptosis,
such as cell shrinkage and cytoplasm hyper-
vacuolisation, were observed in the mono-
cyte and macrophage cultures throughout
the experiment. Four days after treatment
with recombinant porcine IL-1 or IL-10,
the relative numbers of apoptotic blood
monocytes and alveolar macrophages did
not differ from those of untreated cells.
Only 2.0% of the untreated blood mono-
cytes and 6.5% of the untreated alveolar
macrophages showed apoptosis. After
treatment with recombinant porcine IL-1,
percentages of apoptotic blood monocytes
and alveolar macrophages were 2.4 and
5.3%, respectively. Similar results were
obtained after treatment with the different
concentrations of recombinant porcine
IL-10. Between 2.5 and 4.0% of blood
monocytes and between 5.1 and 6.9% of
alveolar macrophages were apoptotic.
4. DISCUSSION
The present study showed a clear rela-
tion between the peak of virus replication
and the onset of apoptosis in the lungs of
PRRSV-infected pigs. Apoptosis occurred
both in virus-infected and in non-infected
cells. Most apoptotic cells were non-
infected, which is in agreement with previ-
ous studies [7, 24, 27].
The pattern of apoptosis in the non-
infected cells was different in lung tissue
compared to broncho-alveolar spaces. In
lung tissue, apoptosis peaked at 14 days PI
and occurred predominantly in monocytes/
macrophages. Earlier studies showed that
a PRRSV infection induces a two- to
Apoptosis in lungs during a PRRSV infection 257
fivefold increase of the number of
broncho-alveolar monocytes/macrophages
[16]. Since apoptosis is a homeostatic
process that serves primarily to eliminate
redundant cells during normal develop-
ment and to eradicate defective cells,
apoptosis of interstitial monocytes/macro-
phages throughout a PRRSV infection may
be a mechanism of cell population control.
However, the process of apoptosis is
apparently not sufficient to completely
control the massive influx of new mono-
cytes since abundant monocytes/macro-
phages cross the interstitium towards the
broncho-alveolar spaces [16].
The mechanism of apoptosis in non-
infected interstitial monocytes/macro-
phages is not known. It has been suggested
that TNF- may be responsible for the
induction of apoptosis in these cells [7].
However, in the present study only a very
weak TNF- production was detected at
14 days PI. Our in vivo data suggest that
IL-1 and IL-10 could be involved in the
induction of apoptosis in non-infected
interstitial monocytes/macrophages. IL-1
and IL-10 levels peaked at 9 days PI and
coincided with a significant increase in
apoptotic cell numbers. Even though, both
cytokines probably do not play a role in the
induction of apoptosis in non-infected
interstitial monocytes/macrophages, since
we failed to induce apoptosis in blood
monocytes or alveolar macrophages
in vitro with recombinant porcine IL-1or
IL-10. Using similar in vitro experiments,
both cytokines were shown to induce apop-
tosis in human cells. IL-1 was shown to
induce apoptosis in a glioblastoma-derived
human cell line when concentrations
between 1 and 200 U/mL were used [6].
Similarly, human monocytes/macrophages
underwent apoptosis following treatment
with 10 ng/mL of IL-10 [33]. Thus, the
exact mechanism by which PRRSV trig-
gers apoptosis in non-infected interstitial
monocytes/macrophages is still under
debate. In addition to cytokines, macro-
phages may produce a lot of other apop-
togenic mediators, such as nitric oxide and
reactive oxygen species, and any or all of
these mediators may contribute to the
induction of apoptosis in non-infected
monocytes/macrophages. Besides these
apoptogenic mediators, viral glycoprotein
GP5, incorporated in cellular debris, may
also be responsible for the induction of
apoptosis in non-infected cells. This glyco-
protein has clearly been shown to be
involved in the induction of apoptosis 26.
Perhaps, induction of apoptosis can also be
alternatively accomplished by attachment
of whole virus particles to the cell without
penetration and ensuing viral infection.
Furthermore, the phagocytic clearance of
cellular debris in viral antigen-positive foci
by monocytes/macrophages may also be
responsible for the apoptosis of non-
infected cells. It has been demonstrated
that phagocytosis triggers macrophage
release of the Fas ligand and induces
apoptosis in bystander leukocytes [5].
Since monocytes/macrophages themselves
express Fas, cross-linking of Fas with the
soluble Fas ligand may indeed induce
apoptosis in non-infected bystander mono-
cytes/macrophages. Both GP5 and phago-
cytosis may explain why the highest
number of apoptotic cells was found in the
proximity of viral antigen-positive foci.
Furthermore, in these regions, apoptotic
cells may have been wrongly defined as
non-infected, since some of these cells
may have been in the early stage of the
PRRSV replication cycle and thus not yet
expressing viral antigens.
In the broncho-alveolar spaces, two
peaks of apoptosis were detected. The first
peak at 9 days PI involved mainly lym-
phocytes. Both T helper cells (CD2+CD4+
CD8–), cytotoxic T cells and NK cells
(CD2+CD4–CD8+), and B cells (wCD1+)
underwent apoptosis. The percentage of
apoptotic cells in T lymphocytes was the
highest at the peak of virus replication in
BAL cells. This suggests that the PRRSV
infection induces apoptosis in broncho-
alveolar T lymphocytes and NK cells. This
is not surprising since T lymphocytes,
activated during the antiviral immune
258 G. Labarque et al.
response, are predisposed to undergo
apoptosis [22]. The second peak of apop-
tosis at 25 days PI can be explained by the
fact that the total BAL cell numbers were
the highest at that time point, as demon-
strated in a previous study [16].
Apoptosis was detected in virus-
infected macrophages during the persistent
stage of the PRRSV infection.  Previous
studies have demonstrated that the appear-
ance of a PRRSV-specific immunity
causes a significant decrease in the number
of viral antigen-positive cells starting at
9 days PI.  Nevertheless, a low number of
single viral antigen-positive cells persists
in the lungs for several weeks [16]. Why
these single viral antigen-positive cells are
able to persist despite the presence of
immunity is not known, but may be in part
attributable to the apoptotic process in
infected cells. It has been suggested that
apoptosis of virus-infected cells may repre-
sent a very efficient mechanism for viruses
to escape from humoral immunity. The
progeny virus which is present in apoptotic
bodies can be taken up by neighbouring
macrophages while protected from anti-
bodies. This type of immune-evasion has
already been described for the human
immunodeficiency virus type 1 [25], her-
pes simplex virus type 2 [2] and Epstein-
Barr virus [13].
Taken together, apoptosis seems to have
a homeostatic effect on the number of
monocytes/macrophages during the mas-
sive influx of new monocytes in the lungs
of PRRSV-infected pigs and may explain
why a low number of single viral antigen-
positive cells persists in the lungs for
several weeks despite the presence of
immunity.
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